Chemoimmunotherapy With Fludarabine and Rituximab Produces Extended Overall Survival and Progression-Free Survival in Chronic Lymphocytic Leukemia: Long-Term Follow-Up of CALGB Study 9712

PURPOSE: The addition of rituximab to fludarabine-based regimens in chronic lymphocytic leukemia (CLL) has been shown to produce high response rates with extended remissions. The long-term follow-up of these regimens with respect to progression, survival, risk of secondary leukemia, and impact of ge...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Woyach, Jennifer A., Ruppert, Amy S., Heerema, Nyla A., Peterson, Bercedis L., Gribben, John G., Morrison, Vicki A., Rai, Kanti R., Larson, Richard A., Byrd, John C.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Clinical Oncology 2011
Assuntos:
Original Reports
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3084002/
https://ncbi.nlm.nih.gov/pubmed/21321292
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2010.31.1811
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados